In GIST, gain-of function mutations of the c-kit gene are present in about 80% [3], whereas a subset of GISTs harbors mutations in platelet-derived growth factor receptor alpha (PDGFRA, about 5%), a CD117 related tyrosine-kinase receptor [10]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.